معرفی
Daniel Merlo is a Research Fellow in the Department of Neuroscience at Monash University, Faculty of Medicine, Nursing and Health Sciences. He is actively engaged in research on multiple sclerosis, with a focus on early detection and monitoring of cognitive decline. His work is conducted within the Van Der Walt research group and involves leadership in national research projects.
Education:
- PhD in Neuroscience, Monash University (awarded October 6, 2021)
His research interests center on subclinical cognitive impairment in multiple sclerosis, including pathophysiology, early diagnosis, and longitudinal monitoring of cognitive trajectories. He applies advanced statistical and machine learning techniques to clinical datasets, particularly in survival analysis and treatment outcomes. His work contributes to improving clinical decision-making and patient monitoring in MS.
Recent publications show a strong trend in applying artificial intelligence to neurology, especially deep learning models for predicting disease progression, alongside traditional clinical epidemiology studies comparing disease-modifying therapies. His work bridges computational methods and clinical neurology.
Dr. Merlo has served as Editor-in-Chief for peer review responsibilities at the journal Multiple Sclerosis and Related Disorders in 2022, reflecting his growing role in academic scholarship and editorial leadership.
He is the Primary Chief Investigator on multiple competitive research grants, including projects funded by Multiple Sclerosis Research Australia, focusing on active monitoring of cognitive function in MS patients over 50 and preclinical changes in cognition. These projects are active into 2027, indicating sustained research leadership.
He is part of the Van Der Walt research group, which specializes in multiple sclerosis and neuroimmunology, and collaborates extensively with national and international researchers through the MSBase Study Group.
